NCT02931357View on ClinicalTrials.gov

Study of a New Medical Device in Gel Formulation Versus Calgel® for the Topical Treatment of Teething in Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

December 31, 2013

Conditions
Pain Teeth
Interventions
DEVICE

Hyaluronic Acid 0.54%

Administration: application of the gel on the gingival tissue, massage it in gently, five to six times a day

DRUG

Calgel®

Administration: application of the gel on the gingival tissue, massage it in gently, three/four times a day (away from meals). In any case the interval between gel applications must be at least 3 hours.

Trial Locations (1)

300209

Opera Contract Research Organization SRL, Timișoara

All Listed Sponsors
collaborator

Opera CRO, a TIGERMED Group Company

OTHER

collaborator

Latis S.r.l.

INDUSTRY

lead

Ricerfarma S.r.l

OTHER

NCT02931357 - Study of a New Medical Device in Gel Formulation Versus Calgel® for the Topical Treatment of Teething in Infants | Biotech Hunter | Biotech Hunter